93 results
Page 2 of 5
DEFA14A
b8x6pacclly
2 Jun 22
Additional proxy soliciting materials
4:30pm
424B5
hl3atstlbuq2p30iz
7 Jun 21
Prospectus supplement for primary offering
4:21pm
8-K/A
EX-1.1
6okqmp a138xv
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-1.1
9q7 62jdu
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
424B5
zsvh1yp7r lheaku
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
kg6hy
17 Feb 21
Prospectus supplement with pricing info
7:14am
8-K/A
EX-99.3
bnn977 366le
30 Dec 20
Financial Statements and Exhibits
5:13pm
8-K
EX-3.3
46z6pwusop ju76
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-10.8
yrgxfm2
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
424B3
yik31piqo 9pe
2 Oct 20
Prospectus supplement
9:25am